Cell Marque recalls
Cell Marque has 16 recalls on record with the FDA and USDA, the earliest in 2016 and the latest reported on 25 Aug 2021. 1 is still ongoing.
Total recalls16since 2016
Last 12 months0reported
Class I00% of total
Ongoing1latest 25 Aug 2021
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 15 94%Class III 1 6%
Why cell marque is recalled
Product types
By year
Ongoing cell marque recalls
1 active| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Device | CLASS III | Antibodies, PSA (ER-PR8) Mouse Monoclonal Antibody recalled | Cell Marque | Lead & Heavy Metals | Nationwide |
All cell marque recalls, newest first
16 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Device | CLASS III | Antibodies, PSA (ER-PR8) Mouse Monoclonal Antibody recalled | Cell Marque | Lead & Heavy Metals | Nationwide |
| Device | CLASS II | RabMAb,CD17, c-kit (YR145) Rabbit Monoclonal Primary Antibody recalled | Cell Marque | Other | 18 states |
| Device | CLASS II | Antibodies, MSH6 , Mouse Monoclonal Antibody recalled by Cell Marque | Cell Marque | Other | 18 states |
| Device | CLASS II | Her2/Neu (c-erbB-2) (CB recalled by Cell Marque | Cell Marque | Other | Nationwide |
| Device | CLASS II | Estrogen Receptor (EP1) recalled by Cell Marque | Cell Marque | Other | Nationwide |
| Device | CLASS II | SV40 (MRQ-4) recalled by Cell Marque | Cell Marque | Other | Nationwide |
| Device | CLASS II | Estrogen Receptor (SP1) recalled by Cell Marque | Cell Marque | Other | Nationwide |
| Device | CLASS II | CD117, c-kit (YR145) recalled by Cell Marque | Cell Marque | Other | Nationwide |
| Device | CLASS II | Adenovirus (20/11 & 2/6); 0.5 mL Catalog # 212M-15; and 7.0 mL recalled | Cell Marque | Other | Nationwide |
| Device | CLASS II | Herpes Simplex Virus II recalled by Cell Marque | Cell Marque | Other | Nationwide |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.